1 Beecher HK. The powerful Placebo. J Am Med Assoc. 1955;159(17):1602–6.
2 Hróbjartsson A, Gøtzsche PC. Is the Placebo powerless? An analysis of clinical trials comparing Placebo with no treatment. N Engl J Med. 2001;344(21):1594–602.
3 Kaptchuk TJ. Powerful Placebo: the dark side of the randomised controlled trial. Lancet. 1998;351(9117):1722–5.
4 Jütte R, Hoppe JD, Scriba P. Stellungnahme des Wissenschaftlichen Beirats der Bundesärztekammer „Placebo in der Medizin“. Dtsch Arztebl. [Internet] 2010;107(28–29):A 1417–21. Available from:
https://www.aerzteblatt.de/archiv/77606/Stellungnahme-des-Wissenschaftlichen-Beirats-der-Bundesaerztekammer-Placebo-in-der-Medizin.
5 Colloca L, Lopiano L, Lanotte M, Benedetti F. Overt versus covert treatment for pain, anxiety, and Parkinson’s disease. Lancet Neurol. 2004;3(11):679–84.
6 Locher C, Frey Nascimento A, Kirsch I, Kossowsky J, Meyer A, Gaab J. Is the rationale more important than deception? A randomized controlled trial of open-label Placebo analgesia. Pain. 2017;158(12):2320–8.
7 Gupta K, Nagappa M, Prasad A, Abrahamyan L, Wong J, Weingarten TN, et al. Risk factors for opioid-induced respiratory depression in surgical patients: a systematic review and meta-analyses. BMJ Open. 2018;8(12):e024086.
8 Jerath A, Panckhurst J, Parotto M, Lightfoot N, Wasowicz M, Ferguson ND, et al. Safety and Efficacy of Volatile Anesthetic Agents Compared With Standard Intravenous Midazolam/Propofol Sedation in Ventilated Critical Care Patients: A Meta-analysis and Systematic Review of Prospective Trials. Anesth Analg. 2017;124(4):1190–9.
9 Breilmann J, Girlanda F, Guaiana G, Barbui C, Cipriani A, Castellazzi M, et al. Benzodiazepines versus Placebo for panic disorder in adults. Cochrane Database Syst Rev. 2019;3:CD010677.
10 Beauchamp TL, Childress JF. Principles of biomedical ethics. New York, Oxford: Oxford University Press; 2019. 496 p.
11 Werner CP, Birkhaeuer J, Locher C, Gerger H, Heimgartner N, Colagiuri B, et al. Price information influences the subjective experience of wine: A framed field experiment. Food Quality and Preference. 2021;92:104223.
12 Gaab J, Kossowsky J, Ehlert U, Locher C. Effects and Components of Placebos with a Psychological Treatment Rationale - Three Randomized-Controlled Studies. Sci Rep. 2019;9(1):1421.
13 Louhiala P, Hemilä H, Puustinen R. Impure Placebo is a useless concept. Theor Med Bioeth. 2015;36(4):279–89.
14 Petrie KJ, Rief W. Psychobiological Mechanisms of Placebo and Nocebo Effects: Pathways to Improve Treatments and Reduce Side Effects. Annu. Rev. Psychol. 2019;70(1):599–625.
15 Grünbaum A. The Placebo concept. Behaviour Research and Therapy. 1981;19(2):157–67.
16 Cuijpers P, Driessen E, Hollon SD, van Oppen P, Barth J, Andersson G. The efficacy of non-directive supportive therapy for adult depression: a meta-analysis. Clin Psychol Rev. 2012;32(4):280–91.
17 Locher C, Koechlin H, Zion SR, Werner C, Pine DS, Kirsch I, et al. Efficacy and Safety of Selective Serotonin Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors, and Placebo for Common Psychiatric Disorders Among Children and Adolescents: A Systematic Review and Meta-analysis. JAMA Psychiatry. 2017;74(10):1011–20.
18 Locher C, Kossowsky J, Gaab J, Kirsch I, Bain P, Krummenacher P. Moderation of antidepressant and Placebo outcomes by baseline severity in late-life depression: A systematic review and meta-analysis. J Affect Disord. 2015;181:50–60.
19 Munkholm K, Paludan-Müller AS, Boesen K. Considering the methodological limitations in the evidence base of antidepressants for depression: a reanalysis of a network meta-analysis. BMJ Open. 2019;9(6):e024886.
20 Moseley JB, O’Malley K, Petersen NJ, Menke TJ, Brody BA, Kuykendall DH, et al. A controlled trial of arthroscopic surgery for osteoarthritis of the knee. N Engl J Med. 2002;347(2):81–8.
21 Jonas WB, Crawford C, Colloca L, Kriston L, Linde K, Moseley B, et al. Are Invasive Procedures Effective for Chronic Pain? A Systematic Review. Pain Med. 2019;20(7):1281–93.
22 Yeung V, Sharpe L, Glozier N, Hackett ML, Colagiuri B. A systematic review and meta-analysis of Placebo versus no treatment for insomnia symptoms. Sleep Med Rev. 2018;38:17–27.
23 Lund K, Vase L, Petersen GL, Jensen TS, Finnerup NB. Randomised controlled trials may underestimate drug effects: balanced Placebo trial design. PLOS ONE. 2014;9(1):e84104.
24 Fässler M, Gnädinger M, Rosemann T, Biller-Andorno N. Use of Placebo interventions among Swiss primary care providers. BMC Health Serv Res. 2009;9:144.
25 Fässler M, Meissner K, Schneider A, Linde K. Frequency and circumstances of Placebo use in clinical practice—a systematic review of empirical studies. BMC Med. 2010;8(1):15.
26 Pepper OHP. A note on the Placebo. Am J Pharm 117;1945:409–12. zitiert nach Kaptchuk TJ, Miller FG. Placebo Effects in Medicine. N Engl J Med 2015;373(1):8–9.
27 Linde K, Atmann O, Meissner K, Schneider A, Meister R, Kriston L, et al. How often do general practitioners use Placebos and non-specific interventions? Systematic review and meta-analysis of surveys. PLOS ONE. 2018;13(8):e0202211.
28 Linde K, Fässler M, Meissner K. Placebo interventions, Placebo effects and clinical practice. Philos Trans R Soc Lond B Biol Sci. 2011;366(1572):1905–12.
29 Kam-Hansen S, Jakubowski M, Kelley JM, Kirsch I, Hoaglin DC, Kaptchuk TJ, et al. Altered Placebo and drug labeling changes the outcome of episodic migraine attacks. Sci Transl Med. 2014;6(218):218ra5.
30 Amanzio M, Benedetti F. Neuropharmacological Dissection of Placebo Analgesia: Expectation-Activated Opioid Systems versus Conditioning-Activated Specific Subsystems. J. Neurosci. 1999;19(1):484–94.
31 Colloca L, Benedetti F. Placebo analgesia induced by social observational learning. Pain. 2009;144(1-2):28–34.
32 Moerman DE, Jonas WB. Deconstructing the Placebo effect and finding the meaning response. Ann Intern Med. 2002;136(6):471–6.
33 Pollo A, Amanzio M, Arslanian A, Casadio C, Maggi G, Benedetti F. Response expectancies in Placebo analgesia and their clinical relevance. Pain. 2001;93(1):77–84.
34 Chen P-HA, Cheong JH, Jolly E, Elhence H, Wager TD, Chang LJ. Socially transmitted Placebo effects. Nat Hum Behav. 2019;3(12):1295–305.
35 Silvestri A, Galetta P, Cerquetani E, Marazzi G, Patrizi R, Fini M, et al. Report of erectile dysfunction after therapy with beta-blockers is related to patient knowledge of side effects and is reversed by Placebo. Eur Heart J. 2003;24(21):1928–32.
36 Rakel D, Barrett B, Zhang Z, Hoeft T, Chewning B, Marchand L, et al. Perception of empathy in the therapeutic encounter: effects on the common cold. Patient Educ Couns. 2011;85(3):390–7.
37 Colloca L, Barsky AJ. Placebo and Nocebo Effects. N Engl J Med. 2020;382(6):554–61.
38 Hall KT, Loscalzo J, Kaptchuk TJ. Genetics and the Placebo effect: the Placebome. Trends Mol Med. 2015;21(5):285–94.
39 Wiegand W. Die Aufklärungspflicht und die Folgen ihrer Verletzung. In: Handbuch des Arztrechts, Honsell (Hrsg.). Zürich: 1994. p. 167 ger.
40 Fellmann W. Arzt und Rechtsverhältnis zum Patienten. In: Arztrecht in der Praxis, Kuhn/Poledna (Hrsg.), 2. Aufl. Zürich/Basel/Genf: 2007. p. 207.
41 Wiegand W. Die Aufklärungspflicht und die Folgen ihrer Verletzung. In: Handbuch des Arztrechts, Honsell (Hrsg.). Zürich: 1994. p. 171 ger.
42 Schöni N. Zulässigkeit von Placebos in der Humanmedizin nach schweizerischem Recht. Diss. Univ. Zürich. Zürich/Basel/Genf: s.n; 2014. p. 70.
43 Trachsel M, Gaab J. Disclosure of incidental constituents of psychotherapy as a moral obligation for psychiatrists and psychotherapists. J Med Ethics. 2016;42(8):493–5.
44 Schöni N. Zulässigkeit von Placebos in der Humanmedizin nach schweizerischem Recht. Diss. Univ. Zürich. Zürich/Basel/Genf: s.n; 2014. p. 71.
45 Kaptchuk TJ, Kerr CE, Zanger A. Placebo controls, exorcisms, and the devil. Lancet. 2009;374(9697):1234–5.
46 Crabtree A. From Mesmer to Freud: Magnetic sleep and the roots of psychological healing. New Haven, London: Yale Univ. Press; 1994. 413 p.
47 Biller-Andorno N. The use of the Placebo effect in clinical medicine—ethical blunder or ethical imperative? Sci Eng Ethics. 2004;10(1):43–50.
48 Evers AWM, Colloca L, Blease C, Gaab J, Jensen KB, Atlas LY, et al. What Should Clinicians Tell Patients about Placebo and Nocebo Effects? Practical Considerations Based on Expert Consensus. Psychother Psychosom. 2021;90(1):49–56.
49 Charlesworth JEG, Petkovic G, Kelley JM, Hunter M, Onakpoya I, Roberts N, et al. Effects of Placebos without deception compared with no treatment: A systematic review and meta-analysis. J Evid Based Med. 2017;10(2):97–107.
50 Wernsdorff M von, Loef M, Tuschen-Caffier B, Schmidt S. Effects of open-label Placebos in clinical trials: a systematic review and meta-analysis. Sci Rep. 2021;11(1):3855.
51 Carvalho C, Caetano JM, Cunha L, Rebouta P, Kaptchuk TJ, Kirsch I. Open-label Placebo treatment in chronic low back pain: a randomized controlled trial. Pain. 2016;157(12):2766–72. Erratum in: Pain. 2017;158(2):365.
52 Carvalho C, Pais M, Cunha L, Rebouta P, Kaptchuk TJ, Kirsch I. Open-label Placebo for chronic low back pain: a 5-year follow-up. Pain. 2021;162(5):1521–7.
53 Kim S, Wollburg E, Roth WT. Opposing breathing therapies for panic disorder: a randomized controlled trial of lowering vs raising end-tidal P(CO2). J Clin Psychiatry. 2012;73(7):931–9.